Detalles de la búsqueda
1.
Efficacy and safety of insulin lispro in obese patients with type 2 diabetes: a retrospective metaanalysis of 7 randomized controlled trials.
Endocr Pract
; 20(5): 389-98, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24325997
2.
Efficacy and safety of insulin lispro in geriatric patients with type 2 diabetes: a retrospective analysis of seven randomized controlled clinical trials.
Aging Clin Exp Res
; 26(1): 77-88, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959960
3.
Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Clin Ther
; 30(5): 858-67, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18555933
4.
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.
Clin Ther
; 29(1): 139-53, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17379054
5.
A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
Clin Ther
; 28(10): 1649-57, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17157120
6.
Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
Clin Ther
; 24(4): 629-38, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12017407
7.
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
Clin Ther
; 26(12): 2034-44, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15823767
8.
How long should insulin be used once a vial is started?
Diabetes Care
; 26(9): 2665-6; discussion 266-9, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12941735
9.
Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes.
Diabetes Care
; 33(6): 1173-5, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20332357
10.
Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.
J Diabetes Complications
; 24(1): 9-19, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-18930413
11.
Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls.
Curr Med Res Opin
; 25(3): 585-97, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19232033
12.
Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes.
J Diabetes Sci Technol
; 2(2): 255-60, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19885351
13.
Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetes.
Curr Med Res Opin
; 24(5): 1395-7, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18394265
14.
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
Curr Med Res Opin
; 24(10): 2943-52, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18786299
15.
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
Curr Med Res Opin
; 24(1): 275-86, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053320
16.
Management of Type 2 diabetes: the role of incretin mimetics.
Expert Opin Pharmacother
; 7(15): 2095-105, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17020435
17.
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.
Diabetes Metab Res Rev
; 22(6): 483-91, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16634116
Resultados
1 -
17
de 17
1
Próxima >
>>